Loading company…
Virtue develops in vitro diagnostic products and platforms for disease screening, diagnosis, and monitoring.
Founded in 2019 and based in Suzhou, China, Virtue develops in vitro diagnostic technologies and products. Its clinical solutions cover screening, diagnosis, treatment monitoring, and prognosis management, with a focus on infectious diseases, tumors, women and children, and chronic diseases. PerkinElmer is its strategic partner.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in